Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
J Neuroimmunol
    May 2023
  1. ABOSEIF A, Toljan K, Mahadeen A, Zeft A, et al
    Pediatric anti-NMDA-receptor autoimmune encephalitis in siblings: Developmental, Electrophysiologic, and Genetic Implications.
    J Neuroimmunol. 2023;379:578107.
    >> Share

  2. TAKEGAMI N, Sakuishi K, Yamaguchi-Takegami N, Egashira S, et al
    Anti-Lactosylceramide antibody positive combined central peripheral demyelination emerging from long-standing juvenile-onset chronic inflammatory polyradiculoneuropathy; a report of two cases.
    J Neuroimmunol. 2023;378:578086.
    >> Share

  3. GE A, Sun Y, Kiker T, Zhou Y, et al
    A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.
    J Neuroimmunol. 2023;379:578105.
    >> Share

  4. MANZANO GS, Rice DR, Zurawski J, Jalkh Y, et al
    Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case report.
    J Neuroimmunol. 2023;379:578099.
    >> Share

  5. XUE Y, Zhang L, Guo R, Shao X, et al
    miR-485 regulates Th17 generation and pathogenesis in experimental autoimmune encephalomyelitis through targeting STAT3.
    J Neuroimmunol. 2023;379:578100.
    >> Share

    April 2023
  6. MO Y, Wang S, Chang Y, Sun X, et al
    A novel rare variant of CNPY3 from familial NMOSD impairs the TLR-mediated immune response.
    J Neuroimmunol. 2023;377:578065.
    >> Share

  7. MULLER-MINY L, Heming M, Lautwein T, Ruck T, et al
    Alemtuzumab treatment exemplifies discordant immune effects of blood and cerebrospinal fluid in multiple sclerosis.
    J Neuroimmunol. 2023;378:578088.
    >> Share

  8. VACARAS V, Muresanu DF, Buzoianu AD, Nistor C, et al
    The role of multiple sclerosis therapies on the dynamic of human gut microbiota.
    J Neuroimmunol. 2023;378:578087.
    >> Share

  9. WANG H, Yi B, Wang M, Wang Y, et al
    Cerebellar ataxia with anti-mGluR1 auto-antibody in a pediatric patient: A case report.
    J Neuroimmunol. 2023;378:578082.
    >> Share

    March 2023
  10. ABBADESSA G, Miele G, Cavalla P, Valentino P, et al
    Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab.
    J Neuroimmunol. 2023;378:578072.
    >> Share

  11. DINOTO A, Zara P, Mariotto S, Ferrari S, et al
    Autoimmune encephalitis misdiagnosis and mimics.
    J Neuroimmunol. 2023;378:578071.
    >> Share

  12. HOWARTH R, Blackwell L, Gombolay G
    Assessment of cognitive status in pediatric anti-NMDA receptor encephalitis during inpatient rehabilitation: A retrospective cohort.
    J Neuroimmunol. 2023;376:578048.
    >> Share

  13. FERREIRA F, Ferreira D, Guimaraes J, Soares-Dos-Reis R, et al
    Recurrent encephalopathy associated with pegylated beta-interferon treatment.
    J Neuroimmunol. 2023;376:578037.
    >> Share

  14. GOU B, Yang P, Feng J, Li Y, et al
    The case report of AQP4 and MOG IgG double positive NMOSD treated with subcutaneous Ofatumumab.
    J Neuroimmunol. 2023;376:578035.
    >> Share

  15. HEBER M, Li Y
    Caution on LRP4 antibody results in patients being evaluated for myasthenia gravis.
    J Neuroimmunol. 2023;377:578063.
    >> Share

  16. PALACIO PL, Pleet ML, Reategui E, Magana SM, et al
    Emerging role of extracellular vesicles in multiple sclerosis: From cellular surrogates to pathogenic mediators and beyond.
    J Neuroimmunol. 2023;377:578064.
    >> Share

  17. ZHOU Q, Yin D, Ma J, Chen S, et al
    The therapeutic effect of ofatumumab in autoimmune encephalitis: A case series.
    J Neuroimmunol. 2023;377:578062.
    >> Share

    January 2023
  18. SERAFINI B, Rosicarelli B, Veroni C, Aloisi F, et al
    Tissue-resident memory T cells in the multiple sclerosis brain and their relationship to Epstein-Barr virus infected B cells.
    J Neuroimmunol. 2023;376:578036.
    >> Share

  19. GARDNER AM, Atkinson JR, Wilkinson NM, Jerome AD, et al
    TAM receptor signaling dictates lesion location and clinical phenotype during experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2023;375:578016.
    >> Share

  20. LI K, Hou L, Tan Y, Huang Y, et al
    Iron metabolism in non-anemic myasthenia gravis patients: A cohort study.
    J Neuroimmunol. 2023;375:578015.
    >> Share

  21. AKAMINE H, Uzawa A, Kojima Y, Ozawa Y, et al
    Role of soluble forms of follicular helper T-cell membrane molecules in the pathogenesis of myasthenia gravis.
    J Neuroimmunol. 2023;375:578014.
    >> Share

    December 2022
  22. MCCOMBE JA, Zivelonghi C, Vorasoot N, Majed M, et al
    AMPAR autoimmunity: Neurological and oncological accompaniments and co-existing neural autoantibodies.
    J Neuroimmunol. 2022;375:578012.
    >> Share

  23. HARAHSHEH E, Callister M, Hasan S, Gritsch D, et al
    Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic review.
    J Neuroimmunol. 2022;373:577994.
    >> Share

  24. ENDRES D, Frye BC, Schlump A, Kuzior H, et al
    Sarcoidosis and obsessive-compulsive symptoms.
    J Neuroimmunol. 2022;373:577989.
    >> Share

  25. CANISSARIO R, Samkoff L, Jean MJ, Williams Z, et al
    GFAP astrocytopathy presenting with profound intracranial hypertension and vision loss.
    J Neuroimmunol. 2022;373:577976.
    >> Share

  26. CURRAN C, Vaitaitis G, Waid D, Volmer T, et al
    Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS).
    J Neuroimmunol. 2022;374:578008.
    >> Share

    November 2022
  27. EATON J, Rahmlow M
    Myelin oligodendrocyte glycoprotein associated transverse myelitis following brain abscess: Case report and literature review.
    J Neuroimmunol. 2022;372:577967.
    >> Share

  28. SHU Y, Ma X, Chen C, Wang Y, et al
    Myelin oligodendrocyte glycoprotein-associated disease is associated with BANK1, RNASET2 and TNIP1 polymorphisms.
    J Neuroimmunol. 2022;372:577937.
    >> Share

    October 2022
  29. LI X, Chu Y, Ma R, Dou M, et al
    Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;373:577995.
    >> Share

  30. CUTELLE C, Balducci C, Cereda D, Fusco ML, et al
    K index utility as diagnostic and prognostic biomarker in the assessment of patients with suspected Multiple Sclerosis.
    J Neuroimmunol. 2022;373:577992.
    >> Share

  31. DE SOUZA TIEPPO EM, da Silva TFF, de Araujo RS, Silva GD, et al
    Primary angiitis of the central nervous system as a mimic of multiple sclerosis: A case report.
    J Neuroimmunol. 2022;373:577991.
    >> Share

  32. BEECHER G, Howe BM, Shelly S, Staff NP, et al
    Plexus MRI helps distinguish the immune-mediated neuropathies MADSAM and MMN.
    J Neuroimmunol. 2022;371:577953.
    >> Share

  33. FEIZI P, Sharma K, Pasham SR, Nirwan L, et al
    Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review.
    J Neuroimmunol. 2022;371:577939.
    >> Share

  34. VERGOOSSEN DLE, Ruiter AM, Keene KR, Niks EH, et al
    Enrichment of serum IgG4 in MuSK myasthenia gravis patients.
    J Neuroimmunol. 2022;373:577978.
    >> Share

    September 2022
  35. FARAJI J, Gustafson C, Bettenson D, Negoro H, et al
    Bladder dysfunction in experimental autoimmune encephalomyelitis reflects clinical severity: A pilot study.
    J Neuroimmunol. 2022;372:577973.
    >> Share

  36. LAMBE J, McGinley MP, Moss BP, Mao-Draayer Y, et al
    Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series.
    J Neuroimmunol. 2022;370:577933.
    >> Share

  37. KASHYAP N, Morris M, Loerinc LB, Benoit M, et al
    The neutrophil-to-lymphocyte ratio is associated with intubation in pediatric anti-NMDA receptor encephalitis: A retrospective study.
    J Neuroimmunol. 2022;370:577931.
    >> Share

  38. KELLY H, Johnson J, Jakubecz C, Serra A, et al
    Prevalence of iatrogenic CNS inflammation at a tertiary neuroimmunology clinic.
    J Neuroimmunol. 2022;370:577928.
    >> Share

  39. HARAMATI A, Rechtman A, Zveik O, Haham N, et al
    IL-6 as a marker for NMOSD disease activity.
    J Neuroimmunol. 2022;370:577925.
    >> Share

  40. MAGALASHVILI D, Mandel M, Dreyer-Alster S, Didikin M, et al
    Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4.
    J Neuroimmunol. 2022;372:577966.
    >> Share

    August 2022
  41. WU H, Chen L, Zhou X, Wu Y, et al
    Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis.
    J Neuroimmunol. 2022;372:577955.
    >> Share

  42. ORTIGOZA-ESCOBAR JD, Fernandez de Sevilla M, Monfort L, Anton J, et al
    Cytokine profile and brain biopsy in a case of childhood-onset central nervous system vasculitis in Noonan syndrome-like disorder due to a novel CBL variant.
    J Neuroimmunol. 2022;369:577917.
    >> Share

  43. JIANG W, Sun X, Huang H, Sun H, et al
    Bilateral parafalcine cortical and leptomeningeal impairment in MOG antibody disease and AQP4 neuromyelitis optica.
    J Neuroimmunol. 2022;369:577898.
    >> Share

  44. NEWSOME SD, Johnson T
    Stiff person syndrome spectrum disorders; more than meets the eye.
    J Neuroimmunol. 2022;369:577915.
    >> Share

  45. GALASSI G
    Comment on "SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fiber neuropathy by J. Finsterer.
    J Neuroimmunol. 2022;369:577901.
    >> Share

  46. CAO B, Luo M, Li J, Lu Y, et al
    Cerebrospinal fluid cystatin C levels in patients with anti-NMDAR encephalitis and other neurological diseases.
    J Neuroimmunol. 2022;369:577900.
    >> Share

  47. RACKE MK, Batish SD, Lisak RP, Barohn RJ, et al
    LRP4 antibody testing in myasthenia gravis.
    J Neuroimmunol. 2022;371:577949.
    >> Share

  48. ISHIZUCHI K, Takizawa T, Ohnuki Y, Sekiguchi K, et al
    Immunodeficiency in patients with thymoma-associated myasthenia gravis.
    J Neuroimmunol. 2022;371:577950.
    >> Share

    July 2022
  49. ALOISI F, Cross AH
    MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis.
    J Neuroimmunol. 2022;371:577935.
    >> Share

  50. FUCHS L, Mausner-Fainberg K, Luban A, Asseyer SE, et al
    CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis.
    J Neuroimmunol. 2022;371:577936.
    >> Share

  51. MURAKAMI K, Miyamoto K, Terayama A, Yoshikawa K, et al
    Acute eye movement-retained internal ophthalmoplegia in atypical Miller Fisher syndrome variants are associated with IgG anti-GQ1b antibodies.
    J Neuroimmunol. 2022;368:577880.
    >> Share

  52. DAS NEVES SP, Serre-Miranda C, Sousa JC, Costa PS, et al
    Lipocalin-2 does not influence EAE clinical score but it increases inflammation in central nervous system.
    J Neuroimmunol. 2022;368:577872.
    >> Share

  53. VAN DER WEELE L, Pollastro S, van Schaik BDC, van Kampen AHC, et al
    Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif) using B cell receptor repertoire analysis.
    J Neuroimmunol. 2022;370:577932.
    >> Share

  54. FONAGER SV, Winther G, Wittenborn TR, Jensen L, et al
    Increased maternofoetal transfer of antibodies in a murine model of systemic lupus erythematosus, but no immune activation and neuroimmune sequelae in offspring.
    J Neuroimmunol. 2022;370:577927.
    >> Share

  55. KASHEKE GDS, Holman SP, Robertson GS
    Fingolimod attenuates gait deficits in mice subjected to experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;370:577926.
    >> Share

  56. STRIJBOS E, van Ostaijen-Ten Dam MM, Vervat C, Schilham MW, et al
    The effect of immunosuppression or thymectomy on the response to tetanus revaccination in myasthenia gravis.
    J Neuroimmunol. 2022;370:577930.
    >> Share

    June 2022
  57. WEIHUA Z, Haitao R, Jie D, Changhong R, et al
    Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases.
    J Neuroimmunol. 2022;370:577918.
    >> Share

  58. RACKE MK, Niles JK, Lorenz RA, Kaufman HW, et al
    Changes in ganglioside antibody positivity rates during the COVID-19 pandemic.
    J Neuroimmunol. 2022;367:577877.
    >> Share

  59. NIE DA, Abud A, Serrano-Gonzalez M, Harappanahally G, et al
    Pediatric stiff limb syndrome with polyautoimmunity of anti-GAD-65, anti-islet cell, and thyroid peroxidase antibodies: A case report and review of literature.
    J Neuroimmunol. 2022;367:577865.
    >> Share

  60. MASI G, Li Y, Karatz T, Pham MC, et al
    The clinical need for clustered AChR cell-based assay testing of seronegative MG.
    J Neuroimmunol. 2022;367:577850.
    >> Share

  61. HU K, Yang Y, Liu J, Chen X, et al
    Susac syndrome with the typical clinical triad: A case report and literature review.
    J Neuroimmunol. 2022;367:577822.
    >> Share

  62. YAO Y, Zhang O, Gu L, Zhang X, et al
    Analysis of risk factors for a poor functional prognosis and relapse in patients with autoimmune encephalitis.
    J Neuroimmunol. 2022;369:577899.
    >> Share

  63. CHAN F, Riminton DS, Ramanathan S, Reddel SW, et al
    Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to "overlap" cases.
    J Neuroimmunol. 2022;369:577904.
    >> Share

    May 2022
  64. YAO Y, Uddin MN, Manley K, Lawrence DA, et al
    Improvements of autism-like behaviors but limited effects on immune cell metabolism after mitochondrial replacement in BTBR T(+)Itpr3(tf)/J mice.
    J Neuroimmunol. 2022;368:577893.
    >> Share

  65. KLEIN CJ, Beecher G, Lamb C, Naddaf E, et al
    LRP4-IgG service line testing in seronegative myasthenia gravis and controls.
    J Neuroimmunol. 2022;368:577895.
    >> Share

  66. PAUL SA, Roy D, Mondal GP, Bhattacharyya R, et al
    Primary angiitis of central nervous system - A challenging diagnosis.
    J Neuroimmunol. 2022;366:577844.
    >> Share

  67. DINOTO A, McKeon A, Vattemi G, Carta S, et al
    Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma.
    J Neuroimmunol. 2022;368:577882.
    >> Share

  68. GILL AJ, Venkatesan A
    Pathogenic mechanisms in neuronal surface autoantibody-mediated encephalitis.
    J Neuroimmunol. 2022;368:577867.
    >> Share

    April 2022
  69. WANG J, Jin L, Zhang X, Yu H, et al
    Activated microglia by (18)F-DPA714 PET in a case of anti-LGI1 autoimmune encephalitis.
    J Neuroimmunol. 2022;368:577879.
    >> Share

  70. FERILLI MAN, Papi C, Sabatelli M, Colosimo C, et al
    MOG autoimmunity mimicking CLIPPERS syndrome: Case report and literature review.
    J Neuroimmunol. 2022;367:577875.
    >> Share

  71. MA R, Chu Y, Dou M, Jing Y, et al
    Matrine inhibits the Wnt3a/beta-catenin/TCF7L2 signaling pathway in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;367:577876.
    >> Share

  72. KYLLESBECH C, Trier N, Slibinskas R, Ciplys E, et al
    Virus-specific antibody indices may supplement the total IgG index in diagnostics of multiple sclerosis.
    J Neuroimmunol. 2022;367:577868.
    >> Share

  73. ODA F, Uzawa A, Ozawa Y, Yasuda M, et al
    Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy.
    J Neuroimmunol. 2022;365:577833.
    >> Share

  74. DEKEYSER C, Naesens L, Offner F, De Vriendt C, et al
    A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome.
    J Neuroimmunol. 2022;367:577866.
    >> Share

  75. MCKEON-MAKKI I, McKeon A, Yang B, Pittock SJ, et al
    Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients.
    J Neuroimmunol. 2022;367:577861.
    >> Share

    March 2022
  76. JIN J, Shneyderman M, Smith MD, Gharagozloo M, et al
    Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis mice.
    J Neuroimmunol. 2022;367:577859.
    >> Share

  77. TOTTENHAM I, Koch M, Camara-Lemarroy C
    Serum HGF and APN2 are associated with disability worsening in SPMS.
    J Neuroimmunol. 2022;364:577803.
    >> Share

  78. NEPAL G, Kharel S, Coghlan MA, Rayamajhi P, et al
    Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis.
    J Neuroimmunol. 2022;364:577812.
    >> Share

  79. WENG J, Du Z, Zhang Y
    CNS limited ANCA-associated vasculitis presenting as an isolated intraparenchymal mass.
    J Neuroimmunol. 2022;364:577791.
    >> Share

  80. DIAZ P, Leveque M, Hautecloque G, Sellal F, et al
    The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit.
    J Neuroimmunol. 2022;366:577842.
    >> Share

  81. SALARI AA, Jand Y, Ghazi-Khansari M
    Antibiotic treatment during pregnancy and lactation in dams exacerbates clinical symptoms and inflammatory responses in offspring with experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;366:577840.
    >> Share

    February 2022
  82. MA J, Yu H, Wang H, Zhang X, et al
    Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
    J Neuroimmunol. 2022;363:577790.
    >> Share

  83. COSTA D, Sardoeira A, Carneiro P, Neves E, et al
    Autoimmune encephalitis: suspicion in clinical practice and mimics.
    J Neuroimmunol. 2022;365:577824.
    >> Share

    January 2022
  84. MOLLER L, Kerwat M, Timmermann L, Simon OJ, et al
    When your cat takes you to the ICU: Miller Fisher/ Guillain-Barre-overlap-syndrome caused by Pasteurella multocida infection resembling wound botulism.
    J Neuroimmunol. 2022;365:577821.
    >> Share

  85. ISMAIL II, Salama S
    A systematic review of cases of CNS demyelination following COVID-19 vaccination.
    J Neuroimmunol. 2022;362:577765.
    >> Share

  86. MA X, Chen C, Fang L, Zhong X, et al
    Dysregulated CD40 and CD40 ligand expression in anti-N-methyl-d-aspartate receptor encephalitis.
    J Neuroimmunol. 2022;362:577762.
    >> Share

  87. KADISH R, Clardy SL, Royston M, Tanvir I, et al
    Clinical burden of relapses in aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder: A single center cohort analysis.
    J Neuroimmunol. 2022;362:577761.
    >> Share

  88. KALININ S, Boullerne AI, Feinstein DL
    Serum levels of lipocalin-2 are elevated at early times in African American relapsing remitting multiple sclerosis patients.
    J Neuroimmunol. 2022;364:577810.
    >> Share

  89. YE F, Dai Y, Wang T, Liang J, et al
    Trans-omics analyses revealed key epigenetic genes associated with overall survival in secondary progressive multiple sclerosis.
    J Neuroimmunol. 2022;364:577809.
    >> Share

  90. BRORSON IS, Eriksson AM, Hogestol E, Leikfoss IS, et al
    Global DNA methylation changes in treated and untreated MS patients measured over time.
    J Neuroimmunol. 2022;364:577808.
    >> Share

  91. URRIOLA N, Blazek K, Adelstein S
    Subunit-specific autoantibodies in autoimmune autonomic ganglionopathy.
    J Neuroimmunol. 2022;363:577805.
    >> Share

    December 2021
  92. RONCHI NR, Silva GD
    Comparison of the clinical syndromes of anti-GABAa versus anti-GABAb associated autoimmune encephalitis: A systematic review.
    J Neuroimmunol. 2021;363:577804.
    >> Share

  93. DIAS DA COSTA M, Leal Rato M, Cruz D, Valadas A, et al
    Longitudinally extensive transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies following SARS-CoV-2 infection.
    J Neuroimmunol. 2021;361:577739.
    >> Share

  94. THOLANCE Y, Antoine JC, Mohr L, Jung M, et al
    Anti-FGFR3 antibody epitopes are functional sites and correlate with the neuropathy pattern.
    J Neuroimmunol. 2021;361:577757.
    >> Share

  95. TALBOT J, Hojsgaard Chow H, Holm Hansen R, von Essen MR, et al
    Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS.
    J Neuroimmunol. 2021;361:577756.
    >> Share

  96. REN H, Fan S, Zhao Y, Guan H, et al
    The changing spectrum of antibody-mediated encephalitis in China.
    J Neuroimmunol. 2021;361:577753.
    >> Share

  97. PUJARI SS, Kulkarni RV, Ojha P, Gursahani R, et al
    Acute haemorrhagic leukoencephalitis (AHLE) - our experience and a short review.
    J Neuroimmunol. 2021;361:577751.
    >> Share

  98. DIAS L, Barbosa L, Martins F, Braz L, et al
    Risk factors for idiopathic myelitis at admission and predictors for late diagnostic change.
    J Neuroimmunol. 2021;361:577747.
    >> Share

  99. SAHA S, Mukherjee S, Guha G, Mukhopadhyay D, et al
    Dynamics of AQP4 upon exposure to seropositive patient serum before and after Rituximab therapy in Neuromyelitis Optica: A cell-based study.
    J Neuroimmunol. 2021;361:577752.
    >> Share

  100. NAGIREDDY RBR, Kumar A, Singh VK, Prasad R, et al
    Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    J Neuroimmunol. 2021;361:577742.
    >> Share

  101. KESHVARI MK, van Someren F, Sheikh S, Galea I, et al
    Eosinophilia during natalizumab treatment: Incidence, risk factors and temporal patterns.
    J Neuroimmunol. 2021;361:577729.
    >> Share

  102. STECK AJ
    Anti-MAG neuropathy: From biology to clinical management.
    J Neuroimmunol. 2021;361:577725.
    >> Share

  103. ADAMEC I, Rogic D, Penz MG, Braun C, et al
    Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab.
    J Neuroimmunol. 2021;362:577788.
    >> Share

  104. SONG J, Yang J, Jing S, Yan C, et al
    Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets.
    J Neuroimmunol. 2021;362:577787.
    >> Share

  105. TOLJAN K, Amin M, Kunchok A, Ontaneda D, et al
    New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure.
    J Neuroimmunol. 2021;362:577785.
    >> Share

    November 2021
  106. CHEN B, Tian DS, Bu BT
    Immunological predictors for the outcome in patients with antibody-mediated autoimmune encephalitis.
    J Neuroimmunol. 2021;362:577779.
    >> Share

  107. CARAVAGNA C
    Comments on "Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine" by , J Neuroimmunol.
    J Neuroimmunol. 2021;362:577780.
    >> Share

  108. WUERCH E, Mishra M, Melo H, Ebacher V, et al
    Quantitative analysis of spinal cord neuropathology in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2021;362:577777.
    >> Share

  109. JIAO L, Li H, Guo S
    Eculizumab treatment for myasthenia gravis subgroups: 2021 update.
    J Neuroimmunol. 2021;362:577767.
    >> Share

  110. HWANG D, Boehm A, Rostami A, Zhang GX, et al
    Oral D-mannose treatment suppresses experimental autoimmune encephalomyelitis via induction of regulatory T cells.
    J Neuroimmunol. 2021;362:577778.
    >> Share

  111. HASSANSHAHI G, Noroozi Karimabad M, Jebali A
    The therapeutic effect of PEGlated nanoliposome of pistachio unsaturated oils and its efficacy to attenuate inflammation in multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial phase I.
    J Neuroimmunol. 2021;362:577768.
    >> Share

  112. FINSTERER J
    SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy.
    J Neuroimmunol. 2021;360:577703.
    >> Share

  113. POURMOGHADDAS Z, Sadeghizadeh A, Tara SZ, Zandifar A, et al
    Longitudinally extensive transverse myelitis as a sign of multisystem inflammatory syndrome following COVID-19 infection: A pediatric case report.
    J Neuroimmunol. 2021;360:577704.
    >> Share

  114. MOLAZADEH N, Filippatou AG, Vasileiou ES, Levy M, et al
    Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder.
    J Neuroimmunol. 2021;360:577702.
    >> Share

  115. FREEDMAN MS, Wojcik J, Holmberg KH, Fluck M, et al
    Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXION.
    J Neuroimmunol. 2021;360:577715.
    >> Share

  116. NILLES C, Poillon G, Deschamps L, Daval M, et al
    IgG4-related pachymeningitis and mastoiditis, associated with cerebral venous thrombosis: A case report.
    J Neuroimmunol. 2021;360:577717.
    >> Share

  117. PANDIT L, Malli C, D'Cunha A, Sudhir A, et al
    Overcoming the challenges in diagnosis of AQP4-IgG positive neuromyelitis optica spectrum disorders in resource poor settings using an indigenized and cost effective cell based assay.
    J Neuroimmunol. 2021;360:577706.
    >> Share

  118. PACHE F, Ringelstein M, Aktas O, Kleiter I, et al
    C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.
    J Neuroimmunol. 2021;360:577699.
    >> Share

  119. MASCIA E, Clarelli F, Zauli A, Guaschino C, et al
    Burden of rare coding variants in an Italian cohort of familial multiple sclerosis.
    J Neuroimmunol. 2021;362:577760.
    >> Share

    October 2021
  120. VAKRAKOU AG, Tzanetakos D, Evangelopoulos ME, Fragoulis GE, et al
    IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients.
    J Neuroimmunol. 2021;361:577759.
    >> Share

  121. FUJIMORI J, Miyazawa K, Nakashima I
    Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.
    J Neuroimmunol. 2021;361:577755.
    >> Share

  122. ZELADA-RIOS L, Pacheco-Barrios K, Galecio-Castillo M, Yamunaque-Chunga C, et al
    Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases.
    J Neuroimmunol. 2021;359:577674.
    >> Share

  123. SRIWASTAVA S, Lisak RP
    Acetylcholine receptor antibodies in a patient with sensory neuropathy.
    J Neuroimmunol. 2021;359:577692.
    >> Share

  124. TANG H, Wang L, Zhou H, Hao X, et al
    Psychiatric symptoms as initial manifestation in neuromyelitis optica spectrum disorder without cortical lesions: A report of two cases.
    J Neuroimmunol. 2021;359:577693.
    >> Share

  125. GOI LDS, Altenhofen S, Nabinger DD, Bonan CD, et al
    Decreased convulsive threshold and memory loss after anti-NMDAR positive CSF injection in zebrafish.
    J Neuroimmunol. 2021;359:577689.
    >> Share

  126. OTA S, Kotani T, Matsuda S, Nishioka D, et al
    Initial serum GM-CSF levels are associated with the severity of cerebral small vessel disease in microscopic polyangiitis patients.
    J Neuroimmunol. 2021;359:577671.
    >> Share

  127. SANTIAGO JA, Babico M, Stitt G, Thomas CA, et al
    Low-dose intrathecal rituximab is a safe and potentially effective treatment for pediatric neuroimmunologic disorders.
    J Neuroimmunol. 2021;359:577687.
    >> Share

  128. ACHIRON A, Mandel M, Dreyer-Alster S, Harari G, et al
    Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study.
    J Neuroimmunol. 2021;361:577746.
    >> Share

  129. KIMURA A, Kato S, Takekoshi A, Yoshikura N, et al
    Autoimmune glial fibrillary acidic protein astrocytopathy resembling isolated central nervous system lymphomatoid granulomatosis.
    J Neuroimmunol. 2021;361:577748.
    >> Share

  130. CHE NN, Chen SY, Li X, Ma JJ, et al
    Autoimmune-mediated secondary-parkinsonism presented with micrographia and cognitive impairment.
    J Neuroimmunol. 2021;361:577738.
    >> Share

  131. SEGAL JP, Phillips S, Dubois RM, Silva JR, et al
    Weight bearing as a measure of disease progression in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2021;361:577730.
    >> Share

    September 2021
  132. OO WM, Giri P, de Souza A
    AstraZeneca COVID-19 vaccine and Guillain- Barre Syndrome in Tasmania: A causal link?
    J Neuroimmunol. 2021;360:577719.
    >> Share

  133. SAMUDRALWAR RD
    Commentary: The spectrum of neurological manifestations related to COVID-19 and vaccinations.
    J Neuroimmunol. 2021;358:577660.
    >> Share

  134. GHOSH R, Dubey S, Mandal A, Ray BK, et al
    Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis.
    J Neuroimmunol. 2021;358:577655.
    >> Share

  135. PAGENKOPF C, Sudmeyer M
    A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.
    J Neuroimmunol. 2021;358:577606.
    >> Share

  136. SRIWASTAVA S, Kataria S, Srivastava S, Kazemlou S, et al
    Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis.
    J Neuroimmunol. 2021;360:577721.
    >> Share

  137. VAN LIEVERLOO GGA, Wieske L, van Schaik IN, Deijs M, et al
    Virus discovery in chronic inflammatory demyelinating polyneuropathy.
    J Neuroimmunol. 2021;358:577668.
    >> Share

  138. MORCH MT, Khorooshi R, Marczynska J, Dubik M, et al
    Mitochondria-A target for attenuation of astrocyte pathology.
    J Neuroimmunol. 2021;358:577657.
    >> Share

  139. SECHI E, Zarbo R, Biancu MA, Chessa P, et al
    Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.
    J Neuroimmunol. 2021;358:577666.
    >> Share

  140. ZHAO X, Yang P
    Hydroxychloroquine alleviates the neurotoxicity induced by anti-ribosomal P antibodies.
    J Neuroimmunol. 2021;358:577648.
    >> Share

  141. BAEK SH, Kim B, Shin JY, Choi SJ, et al
    EBI2-expressing B cells in neuromyelitis optica spectrum disorder with AQP4-IgG: Association with acute attacks and serum cytokines.
    J Neuroimmunol. 2021;358:577637.
    >> Share

  142. GOMBOLAY GY, Gadde JA
    Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review.
    J Neuroimmunol. 2021;358:577653.
    >> Share

  143. XIAO J, Chen X, Shang K, Tang Y, et al
    Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: A pooled analysis of 324 cases from published data and a single-center retrospective study.
    J Neuroimmunol. 2021;360:577718.
    >> Share

  144. PHILLIPS O, Tubre T, Lorenco H, Batish SD, et al
    Limbic encephalitis in a child with ovarian teratoma and influenza B. Case report and critical review of the history of autoimmune anti-N-methyl-d-aspartate receptor encephalitis.
    J Neuroimmunol. 2021;360:577716.
    >> Share

    August 2021
  145. HAYASHI F, Isobe N, Cossu D, Yokoyama K, et al
    Elevated mycobacterium avium subsp. paratuberculosis (MAP) antibody titer in Japanese multiple sclerosis.
    J Neuroimmunol. 2021;360:577701.
    >> Share

  146. FARSHBAFNADI M, Agah E, Rezaei N
    The second brain: The connection between gut microbiota composition and multiple sclerosis.
    J Neuroimmunol. 2021;360:577700.
    >> Share

  147. RIBES GARCIA S, Casanova Estruch B, Gomez Pajares F, Juan Blanco MA, et al
    Prognostic utility of the IgM oligoclonal bands against myelin lipids in multiple sclerosis.
    J Neuroimmunol. 2021;359:577698.
    >> Share

  148. BRAINER-LIMA JPM, Leite BHS, de Araujo CMCS, Dhalia R, et al
    Are Zika virus cross-reactive antibodies against aquaporin-4 associated to Neuromyelitis Optica Spectrum Disorder?
    J Neuroimmunol. 2021;360:577697.
    >> Share

  149. HABEK M, Jakob Brecl G, Basic Kes V, Rogic D, et al
    Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study.
    J Neuroimmunol. 2021;359:577696.
    >> Share

  150. QIAO X, Wang H, Lu L, Chen J, et al
    Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice.
    J Neuroimmunol. 2021;357:577620.
    >> Share

  151. CHAKRABORTY AP, Pandit A, Ray BK, Mukherjee A, et al
    Capgras syndrome and confabulation unfurling anti NMDAR encephalitis with classical papillary thyroid carcinoma: First reported case.
    J Neuroimmunol. 2021;357:577611.
    >> Share

  152. EQUIZA J, Rodriguez-Antiguedad J, Campo-Caballero D, Iruzubieta P, et al
    Autoimmune GFAP astrocytopathy presenting with remarkable CNS hyperexcitability and oculogyric crises.
    J Neuroimmunol. 2021;359:577695.
    >> Share

  153. COSSU D, Yokoyama K, Sato S, Noda S, et al
    PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE).
    J Neuroimmunol. 2021;359:577694.
    >> Share

  154. MIN YG, Ju W, Ha YE, Ban JJ, et al
    Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
    J Neuroimmunol. 2021;359:577691.
    >> Share

  155. HAHAM N, Vaknin-Dembinsky A
    COVID-19 in Cladribine-treated patient with multiple sclerosis.
    J Neuroimmunol. 2021;359:577690.
    >> Share

    July 2021
  156. KRAUS EE, Kakuk-Atkins L, Farinas MF, Jeffers M, et al
    Regulation of autoreactive CD4 T cells by FoxO1 signaling in CNS autoimmunity.
    J Neuroimmunol. 2021;359:577675.
    >> Share

  157. LOVETT-RACKE AE, Yang Y, Liu Y, Gormley M, et al
    B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report.
    J Neuroimmunol. 2021;359:577676.
    >> Share

  158. LAI QL, Cai MT, Zheng Y, Zhang TY, et al
    Seasonal variation in autoimmune encephalitis: A multi-center retrospective study.
    J Neuroimmunol. 2021;359:577673.
    >> Share

  159. YAO Y, Li X, Lin J, Zhang X, et al
    Thymoma-associated autoimmune encephalitis with positive Titin antibodies: A case report.
    J Neuroimmunol. 2021;358:577670.
    >> Share

  160. GUO L, Ren H, Fan S, Guan H, et al
    Autoantibody against the Rab6A/Rab6B in primary autoimmune cerebellar ataxia associated with Sjogren's syndrome: A case report.
    J Neuroimmunol. 2021;359:577667.
    >> Share

  161. WANG J, Yan C, Zhao Z, Chen H, et al
    Sexual dysfunction in patients with myasthenia gravis.
    J Neuroimmunol. 2021;358:577669.
    >> Share

  162. CAPARO-ZAMALLOA C, Alvarez-Toledo K, Yamunaque-Chunga C, Castro-Suarez S, et al
    Autoimmune neurology: Co-occurrence of anti-NMDAR encephalitis and anti-MOG associated disease, report of a case.
    J Neuroimmunol. 2021;358:577663.
    >> Share

  163. LOCKHART A, Boers P
    Paraneoplastic neurologic syndromes with multiple neural autoantibodies: A report of two cases.
    J Neuroimmunol. 2021;358:577665.
    >> Share

  164. LI R, Wang J, Li C, Liu X, et al
    Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone.
    J Neuroimmunol. 2021;356:577604.
    >> Share

  165. DINOTO A, Cheli M, Bratina A, Sartori A, et al
    Bortezomib in anti-N-Methyl-d-Aspartate-Receptor (NMDA-R) encephalitis: A systematic review.
    J Neuroimmunol. 2021;356:577586.
    >> Share

  166. NARESH K, Miraclin TA, Prabhakar AT, Mathew V, et al
    Epstein-Barr virus infection in a woman with aquaporin-4 seropositive neuromyelitis optica.
    J Neuroimmunol. 2021;356:577581.
    >> Share

  167. WONG CK, Hor JY, Loo YP, Heng HS, et al
    High incidence of NMDAR encephalitis among Austronesians: A population-based study in Sabah, Malaysia.
    J Neuroimmunol. 2021;356:577584.
    >> Share

  168. HONGO Y, Kaida K, Komuta Y, Takazaki H, et al
    Cholesterol-added antigens can enhance antiglycolipid antibody activity: Application to antibody testing.
    J Neuroimmunol. 2021;356:577580.
    >> Share

  169. NISHRI Y, Fainstein N, Goldfarb S, Hampton D, et al
    Modeling compartmentalized chronic immune-mediated demyelinating CNS disease in the Biozzi ABH mouse.
    J Neuroimmunol. 2021;356:577582.
    >> Share

  170. MIMPEN M, Damoiseaux J, van Doorn W, Rolf L, et al
    Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patients.
    J Neuroimmunol. 2021;358:577664.
    >> Share

  171. CORTES-VICENTE E, Alvarez-Velasco R, Illa I, Gallardo E, et al
    Comment to "Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis".
    J Neuroimmunol. 2021;358:577659.
    >> Share

  172. IVANOVA M, Voronkova A, Sukhorukov V, Zakharova M, et al
    Different neuroinflammatory gene expression profiles in highly active and benign multiple sclerosis.
    J Neuroimmunol. 2021;358:577650.
    >> Share

  173. KHANMOHAMMADI S, Malekpour M, Jabbari P, Rezaei N, et al
    Genetic basis of Guillain-Barre syndrome.
    J Neuroimmunol. 2021;358:577651.
    >> Share

    June 2021
  174. MOSTAFA GA, Meguid NA, Shehab AAS, Elsaeid A, et al
    Plasma levels of nerve growth factor in Egyptian autistic children: Relation to hyperserotonemia and autoimmunity.
    J Neuroimmunol. 2021;358:577638.
    >> Share

  175. MIRZAEI R, Zamani F, Hajibaba M, Rasouli-Saravani A, et al
    The pathogenic, therapeutic and diagnostic role of exosomal microrna in the autoimmune diseases.
    J Neuroimmunol. 2021;358:577640.
    >> Share

  176. JAKHMOLA S, Upadhyay A, Jain K, Mishra A, et al
    Herpesviruses and the hidden links to Multiple Sclerosis neuropathology.
    J Neuroimmunol. 2021;358:577636.
    >> Share

  177. UZAWA A, Akamine H, Kojima Y, Ozawa Y, et al
    High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis.
    J Neuroimmunol. 2021;358:577634.
    >> Share

  178. FINSTERER J
    Steroid-responsive, transverse myelitis is a known complication of COVID-19.
    J Neuroimmunol. 2021;355:577566.
    >> Share

  179. LEE JK, Kwon S, Han JH, Yoon SE, et al
    Increased proportion of CD20+ T cells after rituximab treatment in patient with neuromyelitis optica later diagnosed with lung B-cell lymphoma: A case report.
    J Neuroimmunol. 2021;355:577564.
    >> Share

  180. GOVIL-DALELA T, Datta I, Williams M
    Refractory NMDA-receptor encephalitis in a teenager: A novel use of Bortezomib.
    J Neuroimmunol. 2021;355:577565.
    >> Share

  181. SON H, Lee WJ, Moon J, Yoon S, et al
    Isolated CNS involvement in eosinophilic granulomatosis with polyangiitis treated with mepolizumab: A case report.
    J Neuroimmunol. 2021;355:577551.
    >> Share

  182. REYES S, Cunningham AL, Kalincik T, Havrdova EK, et al
    Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement.
    J Neuroimmunol. 2021;357:577627.
    >> Share

  183. FINSTERER J, Ghosh R
    Dimensions of SARS-CoV-2 associated Guillain-Barre syndrome.
    J Neuroimmunol. 2021;357:577626.
    >> Share

  184. NIINO M, Fukazawa T, Miyazaki Y, Ura S, et al
    Seasonal fluctuations in serum levels of vitamin D in Japanese patients with multiple sclerosis.
    J Neuroimmunol. 2021;357:577624.
    >> Share

    May 2021
  185. GRISANTI SG, Franciotta D, Garnero M, Zuppa A, et al
    A case series of parainfectious Guillain-Barre syndrome linked to influenza A (H1N1) virus infection.
    J Neuroimmunol. 2021;357:577605.
    >> Share

  186. MANOUCHEHRI N, Guisso DR, Hussain RZ, Minassian BA, et al
    The antioxidant MnTBAP does not effectively downregulate CD4 expression in T cells in vivo.
    J Neuroimmunol. 2021;354:577544.
    >> Share

  187. WANG T, Wang B, Zeng Z, Li H, et al
    Efficacy and safety of bortezomib in rituximab-resistant anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis as well as the clinical characteristics: An observational study.
    J Neuroimmunol. 2021;354:577527.
    >> Share

  188. FINSTERER J, Scorza FA, Scorza CA, Fiorini AC, et al
    Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies.
    J Neuroimmunol. 2021;357:577609.
    >> Share

  189. SVIRIDOVA A, Rogovskii V, Kudrin V, Pashenkov M, et al
    The role of 5-HT2B-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosis.
    J Neuroimmunol. 2021;356:577608.
    >> Share

  190. ROTOLO RA, Demuro J, Drummond G, Little C, et al
    Prophylactic exposure to oral riluzole reduces the clinical severity and immune-related biomarkers of experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2021;356:577603.
    >> Share

  191. SOLTANMORADI S, Tavakolpour V, Moghadasi AN, Kouhkan F, et al
    Expression analysis of NF-kappaB-associated long noncoding RNAs in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients.
    J Neuroimmunol. 2021;356:577602.
    >> Share

  192. KELLY H, Sokola B, Abboud H
    Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients.
    J Neuroimmunol. 2021;356:577599.
    >> Share

  193. ZULIANI L, Marangoni S, De Gaspari P, Rosellini I, et al
    Epidemiology of neuronal surface antibody-mediated autoimmune encephalitis and antibody-based diagnostics.
    J Neuroimmunol. 2021 May 1:577598. doi: 10.1016/j.jneuroim.2021.577598.
    >> Share

    April 2021
  194. YOKOTE H
    Author's response in reply to "Question about data: Importance of serum amyloid A level in patients with multiple sclerosis".
    J Neuroimmunol. 2021;356:577589.
    >> Share

  195. DOPPLER K, Hemprich A, Haarmann A, Brecht I, et al
    Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis.
    J Neuroimmunol. 2021;356:577588.
    >> Share

  196. GARCIA-MANTEIGA JM, Clarelli F, Bonfiglio S, Mascia E, et al
    Identification of differential DNA methylation associated with multiple sclerosis: A family-based study.
    J Neuroimmunol. 2021;356:577600.
    >> Share

  197. MASI G, Spagni G, Campetella L, Monte G, et al
    Assessing the role of a tissue-based assay in the diagnostic algorithm of autoimmune encephalitis.
    J Neuroimmunol. 2021;356:577601.
    >> Share

  198. PAPRI N, Hayat S, Mohammed A, Afsar MNA, et al
    Guillain-Barre syndrome associated with SARS-CoV-2 infection: A case report with long term follow up.
    J Neuroimmunol. 2021;356:577590.
    >> Share

  199. HOU H, Sun Y, Miao J, Gao M, et al
    Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2021;356:577583.
    >> Share

  200. SHEIKH AB, Chourasia PK, Javed N, Chourasia MK, et al
    Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review.
    J Neuroimmunol. 2021;355:577577.
    >> Share

  201. WANG J, Qiu Z, Li D, Dong H, et al
    Anti-contactin-associated protein-like 2 antibody-associated cerebellar ataxia: A case report and literature review.
    J Neuroimmunol. 2021;353:577515.
    >> Share

  202. ZHANG H, Yang Y, Luo X
    Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report.
    J Neuroimmunol. 2021;353:577519.
    >> Share

  203. LI C, Wang J, Sun X, Li R, et al
    The current situation of diagnosis and treatment of neuromyelitis optica spectrum disorder: Experience with 461 cases from a single centre in South China.
    J Neuroimmunol. 2021;353:577506.
    >> Share

  204. DIEM L, Hoepner R, Bagnoud M, Salmen A, et al
    Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literature.
    J Neuroimmunol. 2021;353:577505.
    >> Share

  205. FANG F, Wang Y, Xu W
    Anti-N-methyl-d-aspartate receptor encephalitis associated with intracranial cryptococcal infection: A case report and 2-year follow-up.
    J Neuroimmunol. 2021;353:577502.
    >> Share

  206. DU Q, Shi Z, Chen H, Zhang Y, et al
    Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatus with neuromyelitis optica spectrum disorders.
    J Neuroimmunol. 2021;353:577494.
    >> Share

  207. PRADO MB JR, Narito KM, Adiao KJB
    Anti-GM1 IgM antibody positive axonal variant of Guillain-Barre-syndrome in a pediatric patient with dengue fever.
    J Neuroimmunol. 2021;355:577572.
    >> Share

  208. FAN Z, Zheng D, Wen X, Shen F, et al
    CYP3A5*3 polymorphism and age affect tacrolimus blood trough concentration in myasthenia gravis patients.
    J Neuroimmunol. 2021;355:577571.
    >> Share

  209. DINIZ SN, da Silva CF, de Almeida IT, da Silva Costa FE, et al
    INFbeta treatment affects global DNA methylation in monocytes of patients with multiple sclerosis.
    J Neuroimmunol. 2021;355:577563.
    >> Share

    March 2021
  210. DINOTO A, Bosco A, Sartori A, Bratina A, et al
    Hiccups, severe vomiting and longitudinally extensive transverse myelitis in a patient with prostatic adenocarcinoma and Aquaporin-4 antibodies.
    J Neuroimmunol. 2021;352:577488.
    >> Share

  211. LI X, Hou C, Wu WL, Liang H, et al
    Pediatric anti-N-methyl-d-aspartate receptor encephalitis in southern China: Analysis of 111 cases.
    J Neuroimmunol. 2021;352:577479.
    >> Share

  212. DAY GS, Gordon BA, Bucelli RC, Perrin RJ, et al
    Leveraging molecular biomarkers to make the common diagnosis in the uncommon patient.
    J Neuroimmunol. 2021;352:577474.
    >> Share

  213. COSSU D, Yokoyama K, Sakanishi T, Kuwahara-Arai K, et al
    A mucosal immune response induced by oral administration of heat-killed Mycobacterium avium subsp. paratuberculosis exacerbates EAE.
    J Neuroimmunol. 2021;352:577477.
    >> Share

  214. CHAUDHARY P, Marracci GH, Calkins E, Pocius E, et al
    Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE.
    J Neuroimmunol. 2021;352:577468.
    >> Share

    February 2021
  215. AKAISHI T, Misu T, Takahashi T, Takai Y, et al
    Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders.
    J Neuroimmunol. 2021;351:577467.
    >> Share

  216. CHOUDHARY A, Bhargava A, Khichar S, Pradhan S, et al
    Etiological spectrum, clinico-radiological profile and treatment outcomes of longitudinally extensive transverse myelitis - A prospective study from Northwest India.
    J Neuroimmunol. 2021;351:577456.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016